XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Cash Flow Statements (Unaudited) - USD ($)
 6 Months Ended
Jul. 02, 2017
Jul. 03, 2016
Cash flows from operating activities:    
Net loss $ (6,455,000) $ (10,302,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,972,000 3,678,000
Stock-based compensation expense 395,000 703,000
Deferred loan costs recognized 30,000 435,000
Gain on the sale of assets (2,537,000) (2,391,000)
Provision for excess and obsolete inventory 109,000 86,000
Other noncash items 596,000 (505,000)
Changes in operating assets and liabilities:    
Accounts receivable (2,915,000) 151,000
Inventory (9,451,000) (494,000)
Other current assets 1,232,000 (215,000)
Accounts payable 8,518,000 (369,000)
Accrued and other liabilities 2,548,000 2,288,000
Net cash used in operating activities (5,958,000) (6,935,000)
Cash flows from investing activities:    
Capital expenditures (997,000) (115,000)
Proceeds from sale of assets 2,623,000 11,086,000
Change in restricted cash 0 (6,000,000)
Net cash provided by investing activities 1,626,000 4,971,000
Cash flows from financing activities:    
Capital lease payments (92,000) (51,000)
Principal payments on Term Loan 0 (857,000)
Proceeds from related party note payable 0 1,000,000
Net change in debt under revolving credit agreements 0 2,721,000
Debt issuance and modification costs 0 (379,000)
Indirect repurchase of shares of minimum statutory tax withholdings (108,000) 0
Net cash (used in) provided by financing activities (200,000) 2,434,000
Net (decrease) increase in cash and cash equivalents (4,532,000) 470,000
Cash and cash equivalents at beginning of period 15,270,000 1,349,000
Cash and cash equivalents at end of period $ 10,738,000 $ 1,819,000